Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytoma, Malignant Fibrous × Radiotherapy, Conformal × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Prostatic Neoplasms 3 Lung Neoplasms 3 Glioma 2 Glioblastoma 2 Breast Neoplasms 2 Adenocarcinoma, Bronchiolo-Alveolar 2 Adenocarcinoma of Lung 2 Solitary Fibrous Tumor, Pleural 1 Rectal Neoplasms 1 Radiodermatitis 1 Pancreatic Intraductal Neoplasms 1 Oligodendroglioma 1 Neurotoxicity Syndromes 1 Neuroblastoma 1 Metastatic Malignant Female Reproductive System Neoplasm 1 Mesothelioma, Malignant 1 Inflammation 1 Germinoma 1 Ganglioneuroblastoma 1 Extensive Stage Small Cell Lung Carcinoma 1 Ependymoma 1 Diabetes Insipidus 1 Central Nervous System Nongerminomatous Germ Cell Tumor 1 Central Nervous System Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Brain Neoplasms 1 Astrocytoma 1 Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

pembrolizumab 4 Specimen Handling 3 Doxorubicin 3 Radiotherapy 2 Radiation 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 CTLA-4 Antigen 2 Biopsy 2 tremelimumab 1 talimogene laherparepvec 1 regorafenib 1 pazopanib 1 olaratumab 1 futibatinib 1 fludarabine 1 eribulin 1 durvalumab 1 cabozantinib 1 avelumab 1 aldesleukin 1 X-Rays 1 Trabectedin 1 Standard of Care 1 Quality of Life 1 Immune Checkpoint Inhibitors 1 Ifosfamide 1 Histamine H2 Antagonists 1 Famotidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡